These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10907732)

  • 1. Maintenance ECT in Parkinson's disease.
    Fall PA; Granérus AK
    J Neural Transm (Vienna); 1999; 106(7-8):737-41. PubMed ID: 10907732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Parkinsonism in depressed patients treated with ECT.
    Lebensohn ZM; Jenkins RB
    Am J Psychiatry; 1975 Mar; 132(3):283-5. PubMed ID: 1115272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of depression and parkinsonism during ECT: a case study.
    Dysken M; Evans HM; Chan CH; Davis JM
    Neuropsychobiology; 1976; 2(2-3):81-6. PubMed ID: 1012451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of ECT in patients with parkinsonism.
    Moellentine C; Rummans T; Ahlskog JE; Harmsen WS; Suman VJ; O'Connor MK; Black JL; Pileggi T
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):187-93. PubMed ID: 9608407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease, depression, and ECT: a review and case study.
    Asnis G
    Am J Psychiatry; 1977 Feb; 134(2):191-5. PubMed ID: 835744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
    Borisovskaya A; Bryson WC; Buchholz J; Samii A; Borson S
    Neurodegener Dis Manag; 2016 Apr; 6(2):161-76. PubMed ID: 27033556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electric stimulation (ECT) in Parkinson disease].
    Dam H; Pakkenberg H; Bolwig TG
    Ugeskr Laeger; 1992 Jan; 154(4):183-7. PubMed ID: 1736441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and potential association to Parkinson's disease and dementia with Lewy bodies in patients with major depressive disorder who received maintenance electroconvulsive therapy: a retrospective chart review study.
    Kudo S; Uchida T; Nishida H; Takamiya A; Kikuchi T; Yamagata B; Mimura M; Hirano J
    BMC Psychiatry; 2023 Apr; 23(1):243. PubMed ID: 37041471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of electroconvulsive therapy for depression associated with deep brain stimulation in a patient with post-traumatic Parkinson's Disease: a case study.
    Cunningham MG; Yadollahikhales G; Vitaliano G; van Horne C
    BMC Psychiatry; 2016 Nov; 16(1):399. PubMed ID: 27842519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    Cumper SK; Ahle GM; Liebman LS; Kellner CH
    J ECT; 2014 Jun; 30(2):122-4. PubMed ID: 24810775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkinson's disease and depression].
    Kurokawa K; Yuasa T
    Nihon Rinsho; 2000 Oct; 58(10):2120-4. PubMed ID: 11068458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    J Neural Transm; 1981; 52(3):199-211. PubMed ID: 7310392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of maintenance electroconvulsive therapy in recurrent depression: a naturalistic study.
    Gupta S; Tobiansky R; Bassett P; Warner J
    J ECT; 2008 Sep; 24(3):191-4. PubMed ID: 18772702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.
    Williams NR; Bentzley BS; Sahlem GL; Pannu J; Korte JE; Revuelta G; Short EB; George MS
    Acta Neurol Scand; 2017 Apr; 135(4):407-411. PubMed ID: 27241213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe therapy refractory depression as initial manifestation of Parkinson disease].
    Amann B; Erfurth A; Back T; Grunze H
    Psychiatr Prax; 1999 Jan; 26(1):45-7. PubMed ID: 10087578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance electroconvulsive therapy for Parkinson's disease.
    Aarsland D; Larsen JP; Waage O; Langeveld JH
    Convuls Ther; 1997 Dec; 13(4):274-7. PubMed ID: 9437571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT and Parkinson's disease revisited: a "naturalistic" study.
    Douyon R; Serby M; Klutchko B; Rotrosen J
    Am J Psychiatry; 1989 Nov; 146(11):1451-5. PubMed ID: 2817117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.